financetom
Business
financetom
/
Business
/
LGES executive is optimistic the battery maker will avoid future ICE raids
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LGES executive is optimistic the battery maker will avoid future ICE raids
Sep 16, 2025 12:21 PM

DETROIT (Reuters) -The head of LG Energy Solution's North American business said on Tuesday the battery maker is hopeful about negotiations around visas for its workers following a massive raid on its joint-venture plant with Hyundai in Georgia.

"We're cautiously optimistic that this type of thing will not happen again," said Robert Lee, president for LG Energy Solution in North America.

The raid earlier this month by U.S. authorities led to the arrest of about 475 workers, and set the battery plant at the site back at least two to three months, Hyundai's CEO said last week. Many of those workers returned to Korea last week. 

"We feel really bad for all of our workers as well as our subcontractors who came here on business to install equipment and they were detained," Lee added, speaking at an automotive conference in Detroit.

Reuters previously reported that workers at other LGES production sites went home after the raid because of visa concerns.

Lee reiterated what the CEO of LGES previously stated: production across its facilities would not be meaningfully affected by these changes.

"We have to try to find a plan that works, regardless of various different scenarios. That's what we're doing," Lee said on the sidelines of the event.

In the wake of the raid, Washington and Seoul have agreed to discuss establishing a new visa category for Koreans, South Korean Foreign Minister Cho Hyun has said.

It is typical for automotive complexes to bring on droves of workers to install equipment, especially for battery plants, where the suppliers have expertise. Lee said he is encouraged by the U.S. and Korea's discussions to improve that cumbersome visa approval process.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Baidu share slide wipes $2.4 billion off market value amid speculation over Xi meeting
Baidu share slide wipes $2.4 billion off market value amid speculation over Xi meeting
Feb 17, 2025
HONG KONG (Reuters) - The Hong Kong shares of Baidu plunged on Monday, wiping $2.4 billion off its market value, after the founder of the Chinese search engine giant was not spotted at a rare meeting between President Xi Jinping and corporate leaders. Xi hosted a symposium in Beijing with the country's top tycoons, including Alibaba founder Jack Ma and...
Baidu share slide wipes $2.4 billion off market value amid speculation over Xi meeting
Baidu share slide wipes $2.4 billion off market value amid speculation over Xi meeting
Feb 17, 2025
HONG KONG (Reuters) - The Hong Kong shares of Baidu plunged on Monday, wiping $2.4 billion off its market value, after the founder of the Chinese search engine giant was not spotted at a rare meeting between President Xi Jinping and corporate leaders. Xi hosted a symposium in Beijing with the country's top tycoons, including Alibaba founder Jack Ma and...
Brazil Inc places cautious bet on Argentina turnaround under Milei
Brazil Inc places cautious bet on Argentina turnaround under Milei
Feb 17, 2025
* Brazil companies make new investments or consider ramping up * Economic change is spurring confidence in neighbor * Sectors from consumer goods to oil cite interest By Luciana Magalhaes SAO PAULO, Feb 17 (Reuters) - Brazilian companies are scoping out acquisition targets in Argentina, while beefing up staff and stores in a cautious bet on President Javier Milei's aggressive...
Teva Pharm CEO calls for faster US generic drug approvals
Teva Pharm CEO calls for faster US generic drug approvals
Feb 17, 2025
TEL AVIV, Feb 17 (Reuters) - U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding freezes, the CEO of Israel's Teva Pharmaceutical Industries said on Monday. In the FDA (Food and Drug Administration), there is no speed. I would like them to do things on a regular time because the more...
Copyright 2023-2026 - www.financetom.com All Rights Reserved